We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Rafarma Pharmaceuticals has reached an agreement to be acquired by R. & D. Biocogency Laboratories. Under the agreed terms, Bio-cogency will acquire majority control of Rafarma Pharmaceuticals upon completion of Biocogency’s transition to GAAP ...